Mar 17, 2020 | Press Release
Biologics selected for distribution network based on its expertise in high-touch support for oncology and complex disease patients CARY, N.C., March 17, 2020—Biologics by McKesson, an independent specialty pharmacy for oncology and complex care, was selected by AkaRx,... Jan 17, 2020 | Press Release
CARY, N.C., Jan. 17, 2020—Biologics by McKesson, an independent specialty pharmacy for oncology and other rare and complex therapeutic areas, has been selected by Blueprint Medicines Corporation as a specialty pharmacy provider for AYVAKIT™ (avapritinib) for the... Aug 7, 2019 | Press Release
Exclusive distribution agreement with Daiichi Sankyo, Inc. expands rare disease and complex therapeutic specialty pharmacy needs CARY, N.C. (August 7, 2019) — Biologics by McKesson, an independent specialty pharmacy for oncology and other complex therapeutic areas,... Aug 1, 2019 | Press Release
CARY, N.C., August 1, 2019—Biologics by McKesson, an independent specialty pharmacy for oncology and other complex therapeutic areas, was selected by Bayer HealthCare as a specialty pharmacy provider for NUBEQA® (darolutamide) for the treatment of non-metastatic... Jul 8, 2019 | Press Release
FDA-approved drug is new treatment option for patients with relapsed or penta-refractory multiple myeloma CARY, N.C., July 8, 2019—Biologics by McKesson, an independent specialty pharmacy for oncology and other complex therapeutic areas, announced that it has been... Mar 21, 2019 | Press Release
Exclusive distribution agreement for rare disease therapy strengthens the specialty pharmacy’s footprint beyond oncology CARY, N.C. (March 21, 2019) — Biologics by McKesson continues to expand its capabilities as a specialty pharmacy expert in oncology and complex... 